Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0000950170-24-081949

See Remarks acquired 150,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Sapir Alex See Remarks 2024-07-03 Option exercise +150,000 $3.27 $490,500 193,360 D
Derivatives
Sapir Alex See Remarks 2024-07-03 Option exercise · Stock option - Right to Buy −150,000 2,280,400 D
Loading xslF345X05/ownership.xml…